CLINICAL ROLE -
Novel Combination Therapies in Relapsed/ Refractory Classical Hodgkin Lymphoma
Data shed light on brentuximab vedotin plus nivolumab, bendamustine, or gemcitabine.
Read More
Novel Immunotherapies in Perioperative Setting in Muscle-Invasive Bladder Cancer May Transform Clinical Practice
Systemic treatment options have historically been limited to traditional chemotherapy agents.